Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oleothorax: An Ultrasound Sign of an Old Practice.

Respiration; international review of thoracic diseases·2024
Same author

Improving the management of patients with chronic cardiac and respiratory diseases by extending pulse-oximeter uses: the dynamic pulse-oximetry.

Multidisciplinary respiratory medicine·2024
Same author

Accuracy of a New Pulse Oximetry in Detection of Arterial Oxygen Saturation and Heart Rate Measurements: The SOMBRERO Study.

Sensors (Basel, Switzerland)·2022
Same author

SARS-CoV-2 pandemic in Italy: ethical and organizational considerations.

Multidisciplinary respiratory medicine·2020
Same author

Competence in operative bronchoscopy.

Panminerva medica·2019
Same author

COPD management as a model for all chronic respiratory conditions: report of the 4<sup>th</sup> Consensus Conference in Respiratory Medicine.

Multidisciplinary respiratory medicine·2017

Related Experiment Video

Updated: May 18, 2026

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

Respiratory involvement in inflammatory bowel diseases.

Nadia D'Andrea1, Rossana Vigliarolo, Claudio M Sanguinetti

  • 1Pulmonary and Intensive Care Unit, San Filippo Neri General Hospital, Rome, Italy. n.dandrea@sanfilipponeri.roma.it.

Multidisciplinary Respiratory Medicine
|September 11, 2012
PubMed
Summary

Inflammatory bowel diseases (IBD) can affect the lungs, even without symptoms. Early respiratory investigation in IBD patients is crucial for timely diagnosis and management of potential lung complications.

More Related Videos

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

Related Experiment Videos

Last Updated: May 18, 2026

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
04:45

Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

Published on: June 2, 2022

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
08:58

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography

Published on: July 10, 2018

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

Area of Science:

  • Gastroenterology
  • Pulmonology
  • Immunology

Background:

  • Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), involve intestinal mucosal immune dysregulation.
  • Inflammation in IBD can extend beyond the gastrointestinal tract, affecting organs such as the respiratory system.
  • Respiratory involvement in IBD can range from asymptomatic findings on pulmonary function tests to overt bronchial or lung parenchymal disease.

Purpose of the Study:

  • To highlight the significant incidence of respiratory complications in IBD patients.
  • To emphasize the importance of investigating subclinical and clinical respiratory manifestations in IBD.
  • To underscore the need for early detection of pulmonary involvement in IBD management.

Main Methods:

  • Review of existing literature on IBD and associated respiratory conditions.
  • Analysis of clinical presentations and diagnostic approaches for pulmonary involvement in IBD.
  • Discussion of current therapeutic strategies for respiratory complications in IBD.

Main Results:

  • Respiratory manifestations are a common extraintestinal complication of IBD.
  • Pulmonary involvement can be asymptomatic or present with various lung pathologies.
  • Standard treatments include corticosteroids and antibiotics, with surgery for severe sequelae.

Conclusions:

  • A high incidence of bronchopulmonary complications necessitates careful respiratory evaluation in all IBD patients.
  • Early detection of respiratory involvement, even in asymptomatic individuals, is vital for comprehensive patient care.
  • Proactive screening can lead to better management outcomes for IBD-associated lung disease.